Skip to main content
Press release May 13, 2026

MicroVision Announces First Quarter 2026 Results

Microvision, Inc. (MVIS)

MicroVision Announces First Quarter 2026 Results REDMOND, WA / ACCESSWIRE / May 13, 2026 / MicroVision, Inc. (NASDAQ:MVIS), defining the next generation of lidar-based perception solutions, today announced its first quarter 2026 results. Key Business and Operational Highlights ● Completed value-enhancing asset acquisitions from Luminar Technologies and Scantinel Photonics, accelerating commercial strategy and expanding product portfolio with two 1550nm ToF long-range lidar sensors, IRIS and HALO, and a 1550nm FMCW ultra-long-range lidar sensor. ● Advanced commercial momentum in the Industrial and Security & Defense sectors with new and repeating orders for MOVIA L short-range sensors, IRIS long-range sensors, and integrated software. ● Redefined a new era for lidar, leading with a product portfolio that supports a wide array of applications in many verticals, open software that lowers system cost and expands capability, and high-quality solutions that perform at the right price. ● Accelerated near-term revenue opportunities and amplified customer engagement, actively shipping sensors from existing and acquired inventory. ● Expanded industry-leading product portfolio, with short-, mid-, long-, and ultra-long-range lidar solutions, featuring a mix of solid-state sensors with varying wavelengths, advanced sensor architectures, design-to-cost engineering, and open software solutions. ● Streamlined post-acquisition operating expenses, with reduction in global workforce by approximately 15% and consolidation of engineering and operations functions from Redmond to Orlando location. “We feel very good about our accelerating progress throughout the first quarter, establishing a strong foundation and boldly executing on our strategy to transform the lidar industry,” said Glen DeVos, MicroVision’s Chief Executive Officer. “Following the Q1 asset acquisitions from Luminar and Scantinel, we’ve successfully incorporated the technologies and products, integrated the teams, and streamlined operations. Our broad product portfolio, ready-to-ship sensor inventories, and diversified product roadmap have allowed us to stabilize and strengthen existing commercial relationships while building new opportunities and partnerships.” “We’ve taken on the challenge of redefining lidar, and it is exciting to see the future taking shape,” concluded DeVos. Key Financial Highlights for Q1 2026 ● Revenue for the first quarter of 2026 was $0.9 million, compared to $0.6 million for the first quarter of 2025, primarily as a result of a greater volume of sensors shipped during the first quarter of 2026. ● Total operating expenses for the first quarter of 2026 were $23.9 million, compared to $14.1 million for the first quarter of 2025, with the increase primarily relating to costs stemming from the acquisitions and related integration activities completed during the first quarter of 2026. ● Net loss for the first quarter of 2026 was $25.3 million, or $0.08 per share, compared to a net loss of $28.8 million, or $0.12 per share, for the first quarter of 2025. ● Adjusted EBITDA for the first quarter of 2026 was a $17.2 million loss, compared to a $10.7 million loss for the first quarter of 2025. ● Cash used in operations in the first quarter of 2026 was $16.4 million, compared to cash used in operations in the first quarter of 2025 of $14.1 million. ● The Company ended the first quarter of 2026 with $46.1 million in cash and cash equivalents, including investment securities, compared to $74.8 million at December 31, 2025. Upcoming Investor Events Management will participate in the Deutsche Bank Securities Global Autos, Mobility & Robotics Conference, May 19 – 20, 2026 in New York City. Conference Call and Webcast: Q1 2026 Results MicroVision will host a conference call and webcast, consisting of prepared remarks by management and a question-and-answer session at 1:30 PM PT/4:30 PM ET on Wednesday, May 13, 2026 to discuss the financial results and provide a business update. Analysts and investors may pose questions to management during the live webcast on May 13, 2026. The live webcast can be accessed on the Company’s Investor Relations website under the Events tab HERE. The webcast will be archived on the website for future viewing. About MicroVision MicroVision is defining the next generation of lidar-based perception solutions for automotive, industrial, and security & defense markets. As the industry moves beyond proof of concept toward value, deployment, and commercialization, MicroVision delivers integrated hardware and software solutions designed for real-world performance, automotive-grade reliability, and economic scalability. With engineering centers in the U.S. and Germany, MicroVision leads the industry in depth and breadth of its portfolio, with both short- and long-range lidar solutions, featuring solid-state sensors with varying wavelengths, advanced sensor architectures, design-to-cost engineering, and open software solutions. For more information, visit the Company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision/. MicroVision, MAVIN, MOSAIK, MOVIA, IRIS, and SENTINEL are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners. Non-GAAP information To supplement MicroVision’s condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures “adjusted EBITDA” and “adjusted Gross Profit.” Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; non-cash gains and losses; share-based compensation; restructuring costs; severance expense; and impairment charges. Adjusted Gross Profit is calculated as GAAP gross profit before share-based compensation expense and the amortization of acquired intangibles included in cost of revenue. MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision’s past financial reports, and facilitates comparisons with other companies in the Company’s industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company’s operating results and facilitates comparisons of the Company’s core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision’s operating performance and the valuation of the Company. Adjusted EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision’s business as determined in accordance with GAAP. The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent. The Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted EBITDA. Similarly for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue. Forward-Looking Statements Certain statements contained in this release, including market position, expectations, and likelihood of success; opportunities for customer engagement and revenue; expense reduction; benefits of acquisitions and integration synergies; market position; product portfolio; product and manufacturing capabilities; transaction benefits; access to capital and capital-raising opportunities; and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company’s SEC reports, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason. Investor Relations Contact Jeff Christensen Darrow Associates Investor Relations MVIS@darrowir.com Media Contact Marketing@MicroVision.com Source: MicroVision, Inc. MicroVision, Inc. Consolidated Balance Sheets (In thousands) March 31, December 31, 2026 2025 Assets Current assets Cash and cash equivalents $ 46,120 $ 32,363 Investment securities, available-for-sale - 42,471 Restricted cash, current 485 497 Accounts receivable, net of allowances 732 47 Inventory 4,028 745 Other current assets 2,858 4,989 Total current assets 54,223 81,112 Property and equipment, net 17,300 4,280 Operating lease right-of-use assets 17,929 14,075 Restricted cash, net of current portion 1,189 1,204 Intangible assets, net 13,662 32 Goodwill 3,677 - Other assets 2,224 2,416 Total assets $ 110,204 $ 103,119 Liabilities and shareholders’ equity Current liabilities Accounts payable $ 4,537 $ 1,628 Accrued liabilities 7,542 5,426 Deferred revenue 411 - Derivative liability 2,035 - Notes payable 32,141 19,212 Operating lease liabilities, current 4,985 3,481 Finance lease liabilities, current 13 14 Other current liabilities 99 388 Total current liabilities 51,763 30,149 Warrant liability 1,271 1,875 Operating lease liabilities, net of current portion 16,259 14,034 Finance lease liabilities, net of current portion 21 27 Other long-term liabilities 1,347 1,486 Total liabilities 70,661 47,571 Commitments and contingencies Shareholders’ equity Common stock at par value 322 306 Additional paid-in capital 1,021,218 1,011,835 Accumulated other comprehensive income 559 669 Accumulated deficit (982,556 ) (957,262 ) Total shareholders’ equity 39,543 55,548 Total liabilities and shareholders’ equity $ 110,204 $ 103,119 MicroVision, Inc. Consolidated Statement of Operations (In thousands, except per share data) Three months ended March 31, 2026 2025 Revenue $ 935 $ 589 Cost of revenue 572 550 Gross profit 363 39 Research and development expense 14,445 7,403 Sales, marketing, general and administrative expense 9,511 6,676 Impairment loss on operating lease right-of-use assets 9 - Gain on disposal of fixed assets (108 ) - Total operating expenses 23,857 14,079 Loss from operations (23,494 ) (14,040 ) Interest expense (2,753 ) (12,903 ) Unrealized gain on derivative liability 3,380 842 Unrealized gain on warrant liability 604 1,761 Realized loss on debt extinguishment (3,083 ) (4,654 ) Bargain purchase gain 147 - Other income 87 288 Net loss before taxes $ (25,112 ) $ (28,706 ) Income tax expense (182 ) (73 ) Net loss $ (25,294 ) $ (28,779 ) Net loss per share - basic and diluted $ (0.08 ) $ (0.12 ) Weighted-average shares outstanding - basic and diluted 308,650 235,933 MicroVision, Inc. Consolidated Statements of Cash Flows (In thousands) Three months ended March 31, 2026 2025 Cash flows from operating activities Net loss $ (25,294 ) $ (28,779 ) Adjustments to reconcile net loss to net cash used in operations: Depreciation and amortization 2,368 1,408 Unrealized gain on derivative liability (3,380 ) (842 ) Unrealized gain on warrant liability (604 ) (1,761 ) Loss on debt extinguishment 3,083 4,654 Bargain purchase gain (147 ) - Gain on disposal of fixed assets (108 ) - Impairment of operating lease right-of-use assets 9 - Inventory write-downs 27 - Non-cash interest expense - 7,325 Amortization of debt discount and issuance costs on notes payable 2,743 5,559 Share-based compensation expense 983 1,921 Net accretion of premium on short-term investments (81 ) (118 ) Change in: Accounts receivable (685 ) 674 Inventory 490 (228 ) Other current and non-current assets 308 (2,713 ) Accounts payable 2,800 95 Accrued liabilities 2,116 (348 ) Contract liabilities and other current liabilities 122 (342 ) Operating lease liabilities (1,086 ) (556 ) Other long-term liabilities (107 ) (47 ) Net cash used in operating activities (16,443 ) (14,098 ) Cash flows from investing activities Sales of investment securities 42,528 13,522 Purchases of investment securities - (10,333 ) Cash paid for business combination (33,178 ) - Purchases of property and equipment (143 ) (99 ) Net cash provided by investing activities 9,207 3,090 Cash flows from financing activities Principal payments under finance leases (3 ) (2 ) Principal proceeds from notes payable, net of debt discount and issuance costs 20,732 - Net proceeds from issuance of common stock and warrants 311 8,207 Net cash provided by financing activities 21,040 8,205 Effect of exchange rate changes on cash, cash equivalents, and restricted cash (74 ) 81 Change in cash, cash equivalents, and restricted cash 13,730 (2,722 ) Cash, cash equivalents, and restricted cash at beginning of period 34,064 56,247 Cash, cash equivalents, and restricted cash at end of period $ 47,794 $ 53,525 The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of March 31, 2026 and 2025: March 31, March 31, 2026 2025 Cash and cash equivalents $ 46,120 $ 51,918 Restricted cash, current 485 70 Restricted cash, net of current portion 1,189 1,537 Cash, cash equivalents, and restricted cash $ 47,794 $ 53,525 MicroVision, Inc. Reconciliation of GAAP to Non-GAAP Measures (In thousands) Three months ended March 31, 2026 2025 Reconciliation of Non-GAAP Gross Profit: Gross profit $ 363 $ 39 Inventory related write-downs 27 - Amortization of acquired intangibles - 217 Adjusted Gross Profit $ 390 $ 256 Reconciliation of Non-GAAP Loss: GAAP Net loss $ (25,294 ) $ (28,779 ) Interest expense, net 2,666 12,615 Provision for income taxes 182 73 Depreciation and amortization 2,368 1,408 Unrealized gain on derivative liability (3,380 ) (842 ) Unrealized gain on warrant liability (604 ) (1,761 ) Loss on debt extinguishment 3,083 4,654 Gain on disposal of fixed assets (108 ) - Impairment of operating lease right-of-use assets 9 - Share-based compensation expense 983 1,921 Inventory related write-downs 27 - Acquisition-related costs 1,727 - Restructuring charges 1,139 - Adjusted EBITDA $ (17,202 ) $ (10,711 )
View original release